ロード中...
Melflufen: A Peptide–Drug Conjugate for the Treatment of Multiple Myeloma
Despite the availability of new therapies that have led to improved outcomes for patients with multiple myeloma, most patients will eventually relapse. With triplet and even quadruplet combination therapies becoming standard in the first and second line, many patients will have few treatment options...
保存先:
| 出版年: | J Clin Med |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7601491/ https://ncbi.nlm.nih.gov/pubmed/32992506 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9103120 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|